Management of Cardiac Symptoms in Amyloidosis

Phillip King; Andrew M. Kates

doi:10.1016/j.amjmed.2022.02.005

Management of Cardiac Symptoms in Amyloidosis

Phillip King, Andrew M. Kates

Division of Cardiology

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and ventricular arrhythmias, conduction disturbances, and profound autonomic dysfunction. These symptoms present unique management challenges as compared with patients without CA, and can be very debilitating. Thus, management of the cardiovascular symptoms of these patients plays a central role in their care. This review presents an overview of the typical cardiovascular manifestations encountered in patients with CA and highlights the key management considerations for each.

Original language	English
Pages (from-to)	S9-S12
Journal	American Journal of Medicine
Volume	135
DOIs	https://doi.org/10.1016/j.amjmed.2022.02.005
State	Published - Apr 2022

Keywords

Aortic stenosis
Atrial fibrillation
Cardiac amyloidosis
Conduction disease
Device therapy
Heart failure
Orthostatic hypotension
Symptom management
Ventricular arrhythmias

Access to Document

10.1016/j.amjmed.2022.02.005

Cite this

@article{dcbf932be67142228086f2f96ca3cb9c,

title = "Management of Cardiac Symptoms in Amyloidosis",

abstract = "Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and ventricular arrhythmias, conduction disturbances, and profound autonomic dysfunction. These symptoms present unique management challenges as compared with patients without CA, and can be very debilitating. Thus, management of the cardiovascular symptoms of these patients plays a central role in their care. This review presents an overview of the typical cardiovascular manifestations encountered in patients with CA and highlights the key management considerations for each.",

keywords = "Aortic stenosis, Atrial fibrillation, Cardiac amyloidosis, Conduction disease, Device therapy, Heart failure, Orthostatic hypotension, Symptom management, Ventricular arrhythmias",

author = "Phillip King and Kates, {Andrew M.}",

note = "Funding Information: This article is published as part of a supplement supported by unrestricted educational grants from Alnylam Pharmaceuticals and Janssen Pharmaceuticals. Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = apr,

doi = "10.1016/j.amjmed.2022.02.005",

language = "English",

volume = "135",

pages = "S9--S12",

journal = "American Journal of Medicine",

issn = "0002-9343",

}

TY - JOUR

T1 - Management of Cardiac Symptoms in Amyloidosis

AU - King, Phillip

AU - Kates, Andrew M.

N1 - Funding Information: This article is published as part of a supplement supported by unrestricted educational grants from Alnylam Pharmaceuticals and Janssen Pharmaceuticals. Publisher Copyright: © 2022

PY - 2022/4

Y1 - 2022/4

N2 - Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and ventricular arrhythmias, conduction disturbances, and profound autonomic dysfunction. These symptoms present unique management challenges as compared with patients without CA, and can be very debilitating. Thus, management of the cardiovascular symptoms of these patients plays a central role in their care. This review presents an overview of the typical cardiovascular manifestations encountered in patients with CA and highlights the key management considerations for each.

AB - Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and ventricular arrhythmias, conduction disturbances, and profound autonomic dysfunction. These symptoms present unique management challenges as compared with patients without CA, and can be very debilitating. Thus, management of the cardiovascular symptoms of these patients plays a central role in their care. This review presents an overview of the typical cardiovascular manifestations encountered in patients with CA and highlights the key management considerations for each.

KW - Aortic stenosis

KW - Atrial fibrillation

KW - Cardiac amyloidosis

KW - Conduction disease

KW - Device therapy

KW - Heart failure

KW - Orthostatic hypotension

KW - Symptom management

KW - Ventricular arrhythmias

UR - http://www.scopus.com/inward/record.url?scp=85129927193&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2022.02.005

DO - 10.1016/j.amjmed.2022.02.005

M3 - Article

C2 - 35235819

AN - SCOPUS:85129927193

SN - 0002-9343

VL - 135

SP - S9-S12

JO - American Journal of Medicine

JF - American Journal of Medicine

ER -

Management of Cardiac Symptoms in Amyloidosis

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this